Saxagliptin for the treatment of diabetes - a focus on safety.

about

Emerging use of combination therapies for the management of type 2 diabetes - focus on saxagliptin and dapagliflozin.

P2860

Q38645792-1D4B391B-0EF6-43E1-840A-36F84815B4C0

P2860

Saxagliptin for the treatment of diabetes - a focus on safety.

Item

http://www.wikidata.org/entity/Q38753500

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Saxagliptin for the treatment of diabetes - a focus on safety.

@en

type

Item

label

Saxagliptin for the treatment of diabetes - a focus on safety.

@en

prefLabel

Saxagliptin for the treatment of diabetes - a focus on safety.

@en

P1476

Saxagliptin for the treatment of diabetes - a focus on safety.

@en

P2093

Avivit Cahn

http://www.w3.org/2001/XMLSchema#string

Itamar Raz

http://www.w3.org/2001/XMLSchema#string

Simona Cernea

http://www.w3.org/2001/XMLSchema#string

P2860

Incretin treatment and risk of pancreatitis in patients with type 2 diabetes mellitus: systematic review and meta-analysis of randomised and non-randomised studies

Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies

Increased risk of acute pancreatitis and biliary disease observed in patients with type 2 diabetes: a retrospective cohort study

Antidiabetic treatment with gliptins: focus on cardiovascular effects and outcomes

Diabetic cardiomyopathy: bench to bedside

A comparative study of the binding modes of recently launched dipeptidyl peptidase IV inhibitors in the active site

Saxagliptin overview: special focus on safety and adverse effects

A systematic assessment of cardiovascular outcomes in the saxagliptin drug development program for type 2 diabetes

Dipeptidyl peptidase-4 inhibitors and pancreatitis risk: a meta-analysis of randomized clinical trials

Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus

P304

697-707

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14740338.2016.1159675

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-02-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26923222

http://www.w3.org/2001/XMLSchema#string

Saxagliptin for the treatment of diabetes - a focus on safety.

about

P2860

P2860

Saxagliptin for the treatment of diabetes - a focus on safety.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698